ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Information | RedChip

ENDRA Life Sciences Inc. (NASDAQ: NDRA)


$5.4200
-0.1800 ( +6.69% ) 10.8K

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Market Data


Open


$5.4200

Previous close


$5.6000

Volume


10.8K

Market cap


$2.84M

Day range


$5.1500 - $5.4890

52 week range


$4.0100 - $4,663.7500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Nov 22, 2024
10-q/a Quarterly Reports 59 Nov 21, 2024
10-q Quarterly Reports 6 Nov 19, 2024
8-k 8K-related 16 Nov 15, 2024
nt Quarterly Reports 1 Nov 15, 2024
8-k 8K-related 16 Nov 05, 2024
8-k 8K-related 15 Oct 29, 2024
def Proxies and info statements 6 Sep 16, 2024
pre Proxies and info statements 6 Sep 06, 2024
3/a Insider transactions 1 Sep 05, 2024

Latest News